Antibodies to NMDA receptor, blood-brain barrier disruption and schizophrenia: a theory with unproven links.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2022
   Article
2. Autoantibody Encephalitis: Presentation, Diagnosis, and Management.Journal of clinical neurology (Seoul, Korea) · 2022
   Review
3. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias.European archives of psychiatry and clinical neuroscience · 2018
   Article
4. Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics.Frontiers in psychiatry · 2018
   Review
5. Optimization of an Anti-NMDA Receptor Autoantibody Diagnostic Bioassay.Frontiers in neurology · 2018
   Article
6. 11.7 T MR Imaging Revealed Dilatation of Virchow-Robin Spaces within Hippocampus in Maternally Lipopolysaccharide-exposed Rats.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2017
   Article
7. Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?Frontiers in immunology · 2017
   Review
8. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis.Schizophrenia research · 2016
   Review
9. Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders.Brain sciences · 2016
   Review
10. The role of NMDAR antibody in the etiopathogenesis of schizophrenia.Neuropsychiatric disease and treatment · 2016
    Article
11. Autoimmune encephalopathies.Annals of the New York Academy of Sciences · 2015
    Review
12. Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?Neural plasticity · 2015
    Review

Corrections and comments

• Commented on by
  Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder.2014
• Comment on
  Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.2014

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as